Similar articles

• [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].

  Yamashita J, Kawamura T, Shoin K. Yamashita J, et al. No Shinkei Geka. 1990 Apr;18(4):329-38. No Shinkei Geka. 1990. PMID: 2197571 Review. Japanese. No abstract available.
• The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.

  Peters WP, Kurtzberg J, Atwater S, Borowitz M, Rao M, Currie M, Gilbert C, Shpall EJ, Jones RB, Ross M. Peters WP, et al. Prog Clin Biol Res. 1990;338:121-8. Prog Clin Biol Res. 1990. PMID: 2189135 Clinical Trial. No abstract available.
• High-dose chemotherapy: therapeutic potential in the age of growth factor support.

  Ariad S, Bezwoda WR. Ariad S, et al. Isr J Med Sci. 1992 Jun;28(6):377-85. Isr J Med Sci. 1992. PMID: 1607279 Review.
• Clinical investigators discuss colony-stimulating factors.

  [No authors listed] [No authors listed] Oncology (Williston Park). 1991 Aug;5(8):138-44. Oncology (Williston Park). 1991. PMID: 1834148 No abstract available.
• The role of colony stimulating factors in cancer therapy.

  Morstyn G, Sheridan WP. Morstyn G, et al. Cancer Chemother Biol Response Modif. 1991;12:307-26. Cancer Chemother Biol Response Modif. 1991. PMID: 1718376 Review. No abstract available.